Pfizer Inc: News, Photos, Latest News Headlines about Pfizer Inc

coronavirus, coronavirus vaccine, coronavirus vaccine update, covid 19, covid 19 vaccine, covid 19 vaccine covaxin, oxford vaccine, moderna coronavirus vaccine, india moderna vaccine

Covid-19 vaccine tracker, July 31: Oxford, Johnson & Johnson shots prevent infection in monkeys

August 04, 2020 9:49 am

Coronavirus (COVID-19) vaccine tracker update: The vaccine being developed by Oxford University has just begun phase-III human trials, while the one by Johnson & Johnson is carrying out phase-I and phase-II trials.

Pfizer says delaying drug price hikes after conversation with Donald Trump

July 11, 2018 7:20 am

Pfizer said it would defer price increases that went into effect on July 1 until the end of the year or until the president's drug pricing blueprint goes into effect — whichever is sooner.

Pfizer to buy Hospira for $15 bn

February 06, 2015 1:46 am

Pfizer’s offer of $90 per share represents a premium of 39 per cent to Hospira stock’s close on Wednesday.

Indian units of Pfizer and Wyeth to merge

November 24, 2013 5:54 am

Pfizer India is offering 7 of its shares for every 10 shares of Wyeth.

Teva,Sun Pharma to settle Pfizer patent suit for $2.15 billion

June 13, 2013 3:58 am

Pfizer Inc on Wednesday said a $2.15 billion settlement has been reached with Teva Pharmaceuticals Industries of Israel and Sun Pharmaceutical Industries,Mumbai,for patent-infringement damages resulting from their at-risk launches of generic Protonix in the US.

Pfizer files patent suit against 6 pharma firms

March 06, 2013 12:45 am

The development follows the United States Patent & Trademark Office granting Pfizer a reissue patent covering methods of treating osteoarthritis and other approved conditions with celecoxib.

Weak Prevnar vaccine,emerging market sales hit Pfizer

November 02, 2012 4:41 am

Pfizer Inc reported on Thursday quarterly revenue well below Wall Street expectations,on disappointing sales of its Prevnar pediatric vaccine and a sharp pullback in emerging market revenue.

Pfizer quarterly revenue fall far short of forecasts

November 01, 2012 6:14 pm

Pfizer Inc reported on Thursday quarterly revenue well below Wall Street expectations.

US foreign bribery penalties may lack bite

October 30, 2012 2:08 am

Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets,but harsher penalties may be needed to deter the practice in untapped regions where billions are at stake.